Benzinga
Benzinga
Benzinga
lundi, septembre 28

Fractyl Health Inc

GUTSNASDAQ
Trade with Public
Trade with Public
$0.4891
0.00350.72%
Dern. MÀJ: Sep 28, 9:15 AM
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatComparerRapport sur les stocks

Fractyl Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Fractyl Health (GUTS).

Price Target Range — 8 Quarters

Analyst Consensus — 5 Analysts

5Buy
Consensus RatingBuy# Analysts5Avg. Consensus PT$6Upside to Avg. PT+1181.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →
DateFirmAnalystActionRating ChangePrice Target
Jul 1, 2026Craig-HallumChase KnickerbockerInitiateBuy$4
Jun 4, 2026HC Wainwright & Co.Joseph PantginisMaintainedBuy$8
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a Buy and maintains $8 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a Buy and maintains $8 price target.
Benzinga Newsdesk

PRO
Morgan Stanley Downgrades Fractyl Health to Equal-Weight, Lowers Price Target to $2

Morgan Stanley analyst Michael Ulz downgrades Fractyl Health (NASDAQ:GUTS) from Overweight to Equal-Weight and lowers the price target from $8 to $2.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a Buy and maintains $8 price target.
Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on Fractyl Health, Raises Price Target to $8

Canaccord Genuity analyst Whitney Ijem maintains Fractyl Health (NASDAQ:GUTS) with a Buy and raises the price target from $6 to $8.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Fractyl Health, Lowers Price Target to $8

HC Wainwright & Co. analyst Joseph Pantginis maintains Fractyl Health (NASDAQ: GUTS) with a Buy and lowers the price target from $9 to $8.
Benzinga Newsdesk

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Données de marché fournies par API Benzinga

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved